Peer-reviewedCC BYBiomedicines
Lipid Nanoparticle Delivery of CAR276 mRNA Enables Antigen-Specific Cytotoxicity in T Cells Against Glioblastoma Cells
- 1Department of Hematology/Oncology, University Children’s Hospital, , 72076 Tübingen, Germany
- 2Cluster of Excellence iFIT (EXC2180) “Image-Guided and Functionally Instructed Tumor Therapies”, , 72076 Tübingen, Germany
- 3Institute of Pharmaceutical Technology and Biopharmaceutics, , 48149 Münster, Germany
Related
- Rigorous nested cross-validation and external generalization-gap analysis of a machine-learning classifier for U-251 glioblastoma cytotoxicity
- GITRL COEXPRESSION IN ANTI-GD2 CAR-T CELLS ENHANCES RESISTANCE TO TREG-MEDIATED IMMUNOSUPPRESSION, MITIGATES EXHAUSTION, AND BOOSTS CYTOTOXICITY AGAINST GLIOBLASTOMA SPHEROIDS AND ORGANOTYPIC TUMOR SLICES
- Nanoparticle‐Mediated TIPE1 mRNA Delivery Enhances Paclitaxel Sensitivity in Triple‐Negative Breast Cancer by Modulating RAB7A Ubiquitination‐Associated Stability and Autophagy
- Biogenic Selenium Nanoparticle-Based Nanocomposite Hydrogel for Dual Delivery of Curcumin and Simvastatin for Topical Wound Healing Applications.
- Intracranial dose constraints in IDH-wildtype glioblastoma: a framework for context-specific application
BibTeX
@article{zahedipour2026lipid,
title = {{Lipid Nanoparticle Delivery of CAR276 mRNA Enables Antigen-Specific Cytotoxicity in T Cells Against Glioblastoma Cells}},
author = {Fatemeh Zahedipour and Sogand Sadeghianfard and Silas Wisser and Meshkat Dinarvand and Denise Steiner and Anjana Ramesh and Paul Trosien and Josef Leibold and Markus Mezger and Tahereh Mohammadian Gol},
journal = {Biomedicines},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13702138},
note = {CC BY},
}
RIS
TY - JOUR
TI - Lipid Nanoparticle Delivery of CAR276 mRNA Enables Antigen-Specific Cytotoxicity in T Cells Against Glioblastoma Cells
AU - Fatemeh Zahedipour
AU - Sogand Sadeghianfard
AU - Silas Wisser
AU - Meshkat Dinarvand
AU - Denise Steiner
AU - Anjana Ramesh
AU - Paul Trosien
AU - Josef Leibold
AU - Markus Mezger
AU - Tahereh Mohammadian Gol
PY - 2026
DA - 2026/10/01
JO - Biomedicines
UR - https://europepmc.org/article/PMC/PMC13702138
SN - 2227-9059
ER -